GTC
TEVA icon

Ghost Tree Capital’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Ghost Tree Capital’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-100,000
Closed -$5.24M – 82
2014
Q2 		$5.24M Buy
+100,000
New +$5.11M 3.7% 6

Other funds holding TEVA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Waddell & Reed Financial
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Paulson & Co
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
PointState Capital
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Ghost Tree Capital's TEVA Position: Q3 2014 in Review

Ghost Tree Capital sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2014, closing a stake of 100,000 shares — an estimated $5.24M sold.

Ghost Tree Capital first reported a position in TEVA in Q2 2014 and held it in 1 quarter. The position peaked at $5.24M in Q2 2014. 773 funds tracked by Wall St. Rank hold TEVA as of Q3 2014.

  • Ghost Tree Capital reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2014 after selling out during the quarter.
  • Ghost Tree Capital sold 100,000 Teva Pharmaceutical Industries Limited shares in Q3 2014, an estimated $5.24M.
  • Ghost Tree Capital first reported a position in Teva Pharmaceutical Industries Limited in Q2 2014 and held it in 1 quarter.
  • Ghost Tree Capital's Teva Pharmaceutical Industries Limited position peaked at $5.24M in Q2 2014.
  • 773 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2014.

Based on Ghost Tree Capital's 13F filing for Q3 2014, filed 14 Nov 2014.